Latest Articles

This article explores some of the reasons animal models are used in neuroscience and how this could change in the future.

Metabolomics is expected to increasingly impact precision medicine and diagnostics.

While amyloid-beta has been a central focus in drug development, increasing evidence points to tau pathology as a more accurate predictor of disease progression. This is where the work of Dr. Naoto Watamura could be vital.

Discover the latest in cystic fibrosis treatment, from CFTR modulators to ENaC blockers and emerging inhalable gene therapies.

Discover how scientists imaged the Parkinson’s protein PINK1, unlocking insight into its role in mitochondrial quality control and brain cell survival.

Catching up at the Nordic Precision Medicine Forum 2025 in Stockholm, Technology Networks spoke to Astrid Pedersen, special advisor at the Danish National Genome Center, to learn more about the initiative’s work.

Hear from Shoeb Javed, chief product officer at iGrafx, about AI’s potential to supercharge digital twins in the pharmaceutical sector.

Phenotypic screening has re-emerged as a powerful strategy for identifying drugs based on their observable effects. Discover how phenotypic screening accelerates drug discovery, supports drug repurposing and enables novel therapeutic breakthroughs.

There’s been plenty of discussion about agentic AI across the tech industry, but how can it be of use to life sciences research and development and drug discovery? And how should organizations approach it?

In this interview, Technology Networks spoke with Dr. Joanna Bowtell, professor of physiology, nutrition and metabolism, to learn more about her decorated career, from pioneering research to leadership roles.